The U.S. government stopped sponsoring HIV treatment initiatives in Nigeria and other developing countries on the directive of President Donald Trump. In Nigeria, this choice runs the danger of increasing the number of new HIV infections and AIDS-related deaths, especially with regard to the President’s Emergency Plan for AIDS Relief (PEPFAR). Gaps in prevention, testing, and treatment services have been revealed while AIDS-related mortality have climbed by 10% and new infections have grown by 8% since 2019. Over 20.6 million people worldwide, including about two million HIV-positive Nigerians, have benefited greatly from PEPFAR’s $6.5 billion yearly budget.
Through the initiative, Nigeria has been able to meet the UNAIDS 95-95-95 targets for eradicating HIV as a Public Health issue by 2030. If the financing suspension, which is slated to last for at least 90 days, continues, experts estimate that Nigeria may lose over $1 billion a year in lost access to diagnostic kits, life-saving medications, and medical treatments. Previously, donor organisations have cautioned Nigeria to get ready for a potential aid withdrawal. Yet, inaction resulted in a lack of necessary HIV medications, particularly for those over 40.
US ordered a 90-day freeze on most foreign assistance programs.
As one of the nations with the highest rates of HIV and TB, experts stress the urgent need for domestic funding to support ongoing prevention and treatment initiatives in Nigeria. It has been suggested that specific taxes be introduced, such as stamp duty revenue, to Finance HIV and TB programs without the assistance of donors. Nigeria and other nations that rely largely on foreign help would be significantly impacted by the U.S. government’s recent suspension of funding, which includes vital health initiatives like the President’s Emergency Plan for AIDS Relief (PEPFAR). President Donald Trump issued an executive order requiring a 90-day freeze on the majority of foreign assistance programs while a thorough assessment is conducted.
With an emphasis on accountability and making sure that spending is in line with American interests, this directive represents a larger policy change towards reevaluating U.S. foreign aid expenditures. In expressing this position, Secretary of State Marco Rubio said that the United States would “no longer… blindly dole out money with no return for the American people.” Concerns about the efficiency and supervision of aid initiatives have an impact on this approach. For example, accusations surfaced that PEPFAR monies were indirectly funding actions that went against U.S. policy, like abortions in some nations, which prompted increased scrutiny and demands for thorough assessments of aid recipients.
Healthcare professionals are immediately and visibly impacted.
Nigeria’s response to HIV/AIDS is heavily reliant on external financing. About 82.8% of the nation’s HIV expenditures in 2018 were funded by outside donors, highlighting a significant reliance on foreign aid. Although there have been attempts to boost domestic finance, not much has been accomplished. For instance, domestic public funding decreased to roughly 21% in 2020 after increasing slightly from 21% in 2017 to 29% in 2019. There are serious risks associated with this dependence because any interruption in foreign aid immediately jeopardises the viability of HIV/AIDS programs and may result in shortages of necessary drugs and services.
More so, Nigeria can investigate a number of tactics, including innovative financing mechanisms, international organisations, and Private Sector partnerships, to lessen the effects of decreased foreign support. People and healthcare professionals are immediately and visibly impacted when PEPFAR funding is suspended. For example, three clinics in South Africa run by the nonprofit organisation Engage Men’s Health provide free HIV prevention and management testing and medication. Patients who depend on these organisations for life-saving therapies will be directly impacted as they struggle to continue providing their services as a result of the funding halt.
Related Article: Chamber seeks renewal of AGOA, PEPFAR
Interruptions to treatment put patients who depend on consistent Antiretroviral Therapy at risk of developing drug resistance and elevated virus loads, therefore worsening the epidemic. The effects of the U.S. aid restriction are not unique to Nigeria. Similar issues are being faced by South Africa and Uganda, two nations that also greatly benefit from PEPFAR. A diversified strategy is needed to address this problem, one that includes boosting domestic funding, developing collaborations, and putting creative finance techniques into place to guarantee the Sustainability of health initiatives.